Genetic Signatures’ CEO Dr John Melki will be presenting ShareCafe Micro/Small Cap “Hidden Gems” webinar to be held at 12.30 pm AEST on Friday, 12 February 2021. The webinar is free to join and participants are required to register in advance via the following link: https://us02web.zoom.us/webinar/register/WN_KHst7HftQdSiQwoL6y9ufg

Genetic Signatures Annual Report 2020 released. Click link for more information.

Genetic Signatures’ CEO Dr John Melki will be presenting ShareCafe Micro/Small Cap “Hidden Gems” webinar to be held at 12.30 pm AEST on Friday, 28 August 2020. The webinar is free to join and participants are required to register in advance via the following link: https://us02web.zoom.us/webinar/register/WN_Mjb04hQtSY-nlSbLqWlpSw

Genetic Signatures latest Investor Presentation released. Click link for more information.

Genetic Signatures latest Investor Presentation released. Click link for more information.

Genetic Signatures latest Investor Presentation released. Click link for more information.

A recent article published in Australia’s Sydney Morning Herald with Genetic Signatures’ CEO Dr. John Melki discusses how our novel 3baseTM technology utilised in our EasyScreenTM SARS-CoV-2 Detection Kit has assisted in the quick diagnosis of the virus amongst patients. For more on the article click link “It is ultimately saving lives’: Businesses respond to…

A recent article published in Australia’s Sydney Morning Herald highlights the importance of nationwide screening for COVID-19 testing. For more on the article click link Inside a COVID-19 lab and why more people return inconclusive tests    

Genetic Signatures are pleased to advise that our EasyScreenTM SARS-CoV-2 Detection Kit (the virus that causes COVID-19) has been registered for inclusion in the Australian Register of Therapeutic Goods (ARTG). To view the ASX announcement click here